StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report report published on Thursday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright upped their target price on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.
Get Our Latest Research Report on SenesTech
SenesTech Trading Down 10.1 %
SenesTech (NASDAQ:SNES – Get Free Report) last issued its earnings results on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28. The business had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.71 million. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. On average, research analysts anticipate that SenesTech will post -10.22 EPS for the current year.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- Why Are These Companies Considered Blue Chips?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What is a Secondary Public Offering? What Investors Need to Know
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Use the MarketBeat Dividend Calculator
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.